Incident use of hydroxychloroquine for the treatment of rheumatoid arthritis and systemic lupus erythematosus during the COVID-19 pandemic.
Mercadé-Besora N, Guo Y, Du M, Li X, Ramírez-Anguita JM, Moreno A, Valente A, Villalobos F, Cheng IL, Carrasco-Ribelles LA, van Swieten MM, Merkelbach M, Magoya M, Lasalvia P, Pericàs Pulido P, Berg P, Bosco-Lévy P, Lillini R, Ribeiro R, Bagga TK, Ramella V, Khalid S, Mayer MA, Leis A, Jödicke AM, Burn E, Prieto-Alhambra D, Català M, Prats-Uribe A.
Mercadé-Besora N, et al. Among authors: villalobos f.
Arthritis Care Res (Hoboken). 2024 Mar 25. doi: 10.1002/acr.25331. Online ahead of print.
Arthritis Care Res (Hoboken). 2024.
PMID: 38523562